Tolterodine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Tolterodine. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Dry mouth | 35% |
| Headache | 7% |
| Constipation | 7% |
| Central/peripheral nervous | 5% |
| Gastrointestinal | 5% |
| Fatigue | 4% |
| Diarrhea | 4% |
| Dyspepsia | 4% |
| Influenza-like symptoms | 3% |
| Vision | 3% |
| Psychiatric | 3% |
| Autonomic nervous | 2% |
| General | 2% |
| Urinary | 2% |
| Musculoskeletal | 2% |
| Skin/appendages | 1% |
| Metabolic/nutritional | 1% |
| Resistance mechanism | 1% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Source: FDA labeling via NIH DailyMed (set 25ce804d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.